PMID

Data

Article Title

Organization

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.

Institut De Recherches Servier

[Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].

Emory University

Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.

Institut De Recherches Servier

GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.

Glaxo Group Research